MARKET

SPPI

SPPI

Spectrum Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.040
-0.020
-0.65%
After Hours: 3.110 +0.07 +2.30% 19:59 02/21 EST
OPEN
3.030
PREV CLOSE
3.060
HIGH
3.150
LOW
2.990
VOLUME
1.74M
TURNOVER
--
52 WEEK HIGH
12.15
52 WEEK LOW
2.480
MARKET CAP
343.44M
P/E (TTM)
-2.2862
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SPPI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SPPI stock price target is 9.75 with a high estimate of 13.00 and a low estimate of 4.000.

EPS

SPPI News

More
  • What Awaits Spectrum Pharmaceuticals (SPPI) in Q4 Earnings?
  • Zacks · 3d ago
  • Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call
  • Business Wire · 3d ago
  • Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum Oncology Day on February 13th
  • Business Wire · 02/06 12:00
  • The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
  • Benzinga · 01/28 14:03

Industry

Biotechnology & Medical Research
+0.37%
Pharmaceuticals & Medical Research
+0.54%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About SPPI

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
More

Webull offers kinds of Spectrum Pharmaceuticals, Inc. stock information, including NASDAQ:SPPI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPPI stock news, and many more online research tools to help you make informed decisions.